U.S.A.

2018 Nominees

AbbVie Inc.
Mavyret

Aerie Pharmaceuticals, Inc.
Rhopressa®

Boehringer Ingelheim Pharmaceuticals, Inc.
Ofev

Boehringer Ingelheim Pharmaceuticals, Inc.
Jardiance®

Bristol Myers Squibb Pharmaceuticals, Inc.
Daklinza™

Celgene-Agios
Idhifa

Eli Lilly and Company
Verzenio

Endoceutics, Inc
Intrarosa™

Janssen Biotech, Inc
Invega Trinza

Janssen Research & Development, LLC
Darzalex

Melinta Therapeutics, Inc
Vabomere

Merck & Co., Inc.
Steglatro

Merck & Co., Inc.
Prevymis

Mitsubishi Tanabe Pharma America
Radicava

Neurocrine Biosciences
Ingrezza

Novartis Pharmaceuticals Corporation
Rydapt

Pfizer Inc. & Astellas
Xtandi

Portola Pharmaceuticals
Bevyxxa

TESARO, Inc
Zejula

Teva Pharmaceutical Industries Ltd.
Austedo®

Alexion Pharmaceuticals Inc.
Strensiq®

Alexion Pharmaceuticals Inc.
Kanuma®

Boehringer Ingelheim Pharmaceuticals, Inc.
Praxbind

Genentech & Roche
Hemlibra

Gilead Sciences
Yescarta

GlaxoSmithKline
Shingrix

Janssen Research & Development
Tremfya

Merck & Co., Inc.
Zinplava

Novartis Pharmaceuticals Corporation
Kymriah

Pfizer
Trumemba

Regeneron Pharmaceuticals, Inc. & Sanofi
Dupixent

Spark Therapeutics
Luxturna

Ultragenyx Pharmaceutical
Mepsevii

Abbott
FreeStyle Libre – Flash Glucose Monitoring System

Boston Scientific Corporation
AXIOS™ – Stent and Electrocautery Enhanced Delivery System

Boston Scientific Corporation
SpyGlass

Boston Scientific Corporation
Watchman

Brainscope Company, Inc
BrainScope® One

Foundation Medicine, Inc.
FoundationOneCDx

I Integra LifeSciences Corporation, Inc
Omnigraft® Dermal Regeneration Matrix

Koning Corporation, Inc
KBCT 1000

Medtronic
Implantable System for Remodulin

Otsuka America Pharmaceutical Inc. (OAPI), Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) and Proteus Digital Health
Abilify MyCite